[Ovarian transposition by laparoscopy in young women before curietherapy for cervical cancer].
OBJECTIVE
To evaluate the place of ovarian transposition by laparoscopy in an effort to preserve ovarian function without compromising oncological safety among young women requiring intravaginal brachytherapy before surgery for cervical cancer.


METHODS
The series was represented by 20 cases, all FIGO stage I squamous cell malignant diseases of the cervix. Mean age: 32 years (range 23-40). Oophoropexy (7 instances) or lateral high ovarian transposition (13 instances) was performed by laparoscopy, just before brachytherapy using cesium 137.


RESULTS
Continued hormonal function was achieved in 58% of the available cases, 50% (3/6) after oophoropexy, 68% (8/11) after ovarian transposition. Mean follow-up was 8.5 years (range 5-13). The mean radiation dose absorbed by the displaced ovary was 2.6 Gy (range 1. 2-5.9).


CONCLUSIONS
Ovarian transposition through laparoscopy before brachytherapy should be advised for selected stage I squamous type malignant tumor size 2 cm without lymphatic/vascular channel invasion by neoplastic emboli and without lymph node involvement. This procedure has been abandoned in our institution, instead of this, primary surgical treatment is accomplished (laparoscopically-assisted vaginal) radical hysterectomy is associated with orthotopic ovarian conservation.
Le Bouëdec
G
G
Centre Régional de Lutte Contre le Cancer Jean Perrin, 58, rue Montalembert, B.P. 392, 63011 Clermont-Ferrand Cedex.
Rabishong
B
B
Canis
M
M
Achard
J L
JL
Pomel
C
C
Dauplat
J
J
D000328:Adult; D001918:Brachytherapy; D002294:Carcinoma, Squamous Cell / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D002588:Cesium Radioisotopes / Q000627:therapeutic use; D005260:Female; D006801:Humans; D010535:Laparoscopy; D009367:Neoplasm Staging; D010053:Ovary / Q000601:surgery*; D002583:Uterine Cervical Neoplasms / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery
D002588:Cesium Radioisotopes